Rossari Biotech (India) Price Prediction

ROSSARI Stock   822.80  5.35  0.65%   
At the present time, the relative strength index (RSI) of Rossari Biotech's share price is approaching 38 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Rossari Biotech, making its price go up or down.

Oversold Vs Overbought

38

 
Oversold
 
Overbought
The successful prediction of Rossari Biotech's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Rossari Biotech Limited, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Rossari Biotech's stock price prediction:
Quarterly Earnings Growth
0.072
EPS Estimate Current Year
23.47
EPS Estimate Next Year
28.8
Wall Street Target Price
988.25
Quarterly Revenue Growth
0.031
Using Rossari Biotech hype-based prediction, you can estimate the value of Rossari Biotech Limited from the perspective of Rossari Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Rossari Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Rossari because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Rossari Biotech after-hype prediction price

    
  INR 817.45  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Rossari Biotech Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
619.36621.26899.20
Details
Naive
Forecast
LowNextHigh
818.50820.40822.30
Details
Earnings
Estimates (0)
LowProjected EPSHigh
6.476.787.10
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Rossari Biotech. Your research has to be compared to or analyzed against Rossari Biotech's peers to derive any actionable benefits. When done correctly, Rossari Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Rossari Biotech.

Rossari Biotech After-Hype Price Prediction Density Analysis

As far as predicting the price of Rossari Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Rossari Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Rossari Biotech, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Rossari Biotech Estimiated After-Hype Price Volatility

In the context of predicting Rossari Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Rossari Biotech's historical news coverage. Rossari Biotech's after-hype downside and upside margins for the prediction period are 815.55 and 819.35, respectively. We have considered Rossari Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
822.80
815.55
Downside
817.45
After-hype Price
819.35
Upside
Rossari Biotech is very steady at this time. Analysis and calculation of next after-hype price of Rossari Biotech is based on 3 months time horizon.

Rossari Biotech Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Rossari Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rossari Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Rossari Biotech, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.12 
1.90
 0.00  
  10.29 
0 Events / Month
1 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
822.80
817.45
0.00 
0.00  
Notes

Rossari Biotech Hype Timeline

Rossari Biotech is at this time traded for 822.80on National Stock Exchange of India of India. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -10.29. Rossari is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.12%. %. The volatility of related hype on Rossari Biotech is about 2.21%, with the expected price after the next announcement by competition of 812.51. About 68.0% of the company outstanding shares are owned by corporate insiders. The book value of Rossari Biotech was at this time reported as 202.14. The company recorded earning per share (EPS) of 25.1. Rossari Biotech last dividend was issued on the 16th of August 2024. Assuming the 90 days trading horizon the next forecasted press release will be within a week.
Check out Rossari Biotech Basic Forecasting Models to cross-verify your projections.

Rossari Biotech Related Hype Analysis

Having access to credible news sources related to Rossari Biotech's direct competition is more important than ever and may enhance your ability to predict Rossari Biotech's future price movements. Getting to know how Rossari Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Rossari Biotech may potentially react to the hype associated with one of its peers.

Rossari Biotech Additional Predictive Modules

Most predictive techniques to examine Rossari price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Rossari using various technical indicators. When you analyze Rossari charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Rossari Biotech Predictive Indicators

The successful prediction of Rossari Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Rossari Biotech Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Rossari Biotech based on analysis of Rossari Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Rossari Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Rossari Biotech's related companies.

Story Coverage note for Rossari Biotech

The number of cover stories for Rossari Biotech depends on current market conditions and Rossari Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Rossari Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Rossari Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Rossari Biotech Short Properties

Rossari Biotech's future price predictability will typically decrease when Rossari Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Rossari Biotech Limited often depends not only on the future outlook of the potential Rossari Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rossari Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding55.3 M
Cash And Short Term Investments667.9 M

Complementary Tools for Rossari Stock analysis

When running Rossari Biotech's price analysis, check to measure Rossari Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rossari Biotech is operating at the current time. Most of Rossari Biotech's value examination focuses on studying past and present price action to predict the probability of Rossari Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rossari Biotech's price. Additionally, you may evaluate how the addition of Rossari Biotech to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.